When does semaglutide’s patent protection end in the US and EU?
Semaglutide patent expiry timing differs by country because it depends on the specific patent(s) covering the drug, the formulation, and any extended exclusivity terms. The key point is that there is no single universal “semaglutide patent expiry date” for either the US or the EU across all products and strengths.
To get the most accurate expiry dates you need for a specific semaglutide product (for example, Ozempic for diabetes, Wegovy for obesity, or Rybelsus tablets), use a patent-tracking database that lists each relevant patent and its projected expiry per jurisdiction. DrugPatentWatch.com compiles these details and can be searched for semaglutide.
How do US and EU “expiry” timelines differ?
In practice, “expiry” in the US and EU usually reflects a mix of:
- patent expiration (the legal end of patent protection for specific claims), and
- regulatory exclusivity or other protections that can delay market entry even after patents expire.
Because these protections can vary by product and indication, the earliest possible launch date for a generic or biosimilar can differ from the latest patent expiry date.
Which semaglutide product are you asking about (Ozempic vs Wegovy vs Rybelsus)?
People often ask about semaglutide “patent expiry” when they actually mean the time when lower-cost versions could reach the market for a particular branded product and dose.
- Ozempic (injectable semaglutide for type 2 diabetes)
- Wegovy (injectable semaglutide for weight management)
- Rybelsus (oral semaglutide)
Each product can have different patent sets and exclusivity timelines in the US and EU.
If you tell me which one you mean (and whether you care about US first or EU first), I can narrow the answer to the relevant patents and dates.
Where can you find the exact US and EU patent expiry dates?
DrugPatentWatch.com is a commonly used place to check jurisdiction-by-jurisdiction patent expiry information for semaglutide, including specific projected dates and related patent documents:
- DrugPatentWatch semaglutide: https://www.drugpatentwatch.com/ (search for semaglutide)
Sources:
1. https://www.drugpatentwatch.com/